PRONULIFE®LvUCare-Uric Acid Management and Liver Care Probiotics
Product description
The PRONULIFE®LvUCare probiotic combination has been validated through animal experiments to prevent and treat metabolic syndrome symptoms, including fatty liver and hyperuricemia-induced inflammation. In alcohol-fed mouse models, it reduced triglyceride accumulation, alleviating fatty liver. Rat experiments showed prevention of hyperuricemia and were published in international journals. Two clinical studies revealed its ability to break down uric acid in the digestive tract, protecting the liver and reducing kidney burden. Supported by a Taiwanese invention patent (TW I764598) and multiple patent applications in China and the United States, its effectiveness in promoting metabolism and assisting those with socializing habits has been confirmed through animal and human experiments, contributing to overall health.
→See more: https://lihi.cc/R2Dyu/IIN_LvUcare
Read more
→See more: https://lihi.cc/R2Dyu/IIN_LvUcare
Specifications
| Categories | Clinical trials; Contract manufacturing; Probiotics |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
| Supplied from | Taiwan, China |
| Product Applications | Food Supplements; Natural Products |
| Product Certifications | Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Quality assurance; Sustainable; Traceable |
.jpg)
PRONULIFE®LvUCare-Uric Acid Management and Liver Care Probiotics
-comp289331.png)
